ARTICLE | Company News
Alexza, Valeant Pharmaceuticals deal
October 25, 2010 7:00 AM UTC
Valeant's Biovail Laboratories International SRL subsidiary returned rights in the U.S. and Canada to Alexza for bipolar disorder and schizophrenia candidate Staccato loxapine ( AZ-004). Valeant gaine...